PMID- 30625244 OWN - NLM STAT- MEDLINE DCOM- 20190306 LR - 20190306 IS - 1540-8191 (Electronic) IS - 0886-0440 (Linking) VI - 34 IP - 1 DP - 2019 Jan TI - Severe structural deterioration of small aortic bioprostheses treated with valve-in-valve transcatheter aortic valve implantation. PG - 7-13 LID - 10.1111/jocs.13976 [doi] AB - OBJECTIVES: The aim of this study was to evaluate outcomes of valve-in-valve transcatheter aortic valve implantation (VIV-TAVI) in patients with degenerated small bioprostheses. METHODS: Outcomes of consecutive 27 high-risk patients (logistic EuroSCORE 35.5 +/- 18.5%) with a mean age of 81.0 +/- 5.9 years who underwent VIV-TAVI for degenerated small bioprostheses (19 mm-11.1%; 20 mm-11.1%; 21 mm-77.8%) were analyzed. Medtronic CoreValve (n = 11) or CoreValve Evolut-R prostheses (n = 16) were implanted. Follow-up was 3.2 +/- 2.0 years. RESULTS: Early mortality was 11.1%. One patient died intraoperatively due to left ventricle perforation, two others during the in-hospital period as a result of sudden cardiac death and pulmonary embolism. VIV-TAVI was completed in 26 cases (96.3%-success rate). Two patients required pacemaker implantation. Acute kidney injury occurred in two other patients. At discharge, mean transvalvular gradient was 19.2 +/- 9.5 mmHg and in 25.9% of patients mean gradient exceeded 20 mmHg. Overall mortality was 25.9% and mortality from cardiac or unknown causes at 18.5%. Ninety percent of survivors were in New York Heart Association (NYHA) class I or II. CONCLUSIONS: Transfemoral VIV-TAVI in patients with small, degenerated bioprostheses appears to be a promising alternative to surgery. Although the vast majority of patients have significant improvement in their NYHA class, the rate of persistent, residual gradients is relatively high and will need to be followed closely with serial echocardiograms. CI - (c) 2019 Wiley Periodicals, Inc. FAU - Stankowski, Tomasz AU - Stankowski T AUID- ORCID: 0000-0003-2054-8199 AD - Department of Cardiac Surgery, Sana Heart Center Cottbus, Cottbus, Germany. FAU - Aboul-Hassan, Sleiman Sebastian AU - Aboul-Hassan SS AUID- ORCID: 0000-0003-4544-7466 AD - Department of Cardiac Surgery, MEDINET Heart Center Ltd., Nowa Sol, Poland. FAU - Seifi-Zinab, Farzaneh AU - Seifi-Zinab F AD - Department of Cardiac Surgery, Sana Heart Center Cottbus, Cottbus, Germany. FAU - Herwig, Volker AU - Herwig V AD - Department of Cardiac Surgery, Sana Heart Center Cottbus, Cottbus, Germany. FAU - Kubikova, Miroslava AU - Kubikova M AD - Department of Cardiac Surgery, Sana Heart Center Cottbus, Cottbus, Germany. FAU - Harnath, Axel AU - Harnath A AD - Department of Cardiac Surgery, Sana Heart Center Cottbus, Cottbus, Germany. FAU - Fritzsche, Dirk AU - Fritzsche D AD - Department of Cardiac Surgery, Sana Heart Center Cottbus, Cottbus, Germany. FAU - Perek, Bartlomiej AU - Perek B AD - Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poznan, Poland. LA - eng PT - Journal Article DEP - 20190109 PL - United States TA - J Card Surg JT - Journal of cardiac surgery JID - 8908809 SB - IM MH - Aged, 80 and over MH - Aortic Valve/diagnostic imaging/*surgery MH - Aortic Valve Stenosis/diagnosis/*surgery MH - Bioprosthesis/*adverse effects MH - Echocardiography MH - Female MH - Fluoroscopy MH - Follow-Up Studies MH - *Heart Valve Prosthesis MH - Humans MH - Male MH - Prosthesis Design MH - Reoperation MH - Severity of Illness Index MH - Transcatheter Aortic Valve Replacement/*methods MH - Treatment Outcome OTO - NOTNLM OT - outcomes OT - reintervention OT - structural valve deterioration OT - transcatheter aortic valve implantation EDAT- 2019/01/10 06:00 MHDA- 2019/03/07 06:00 CRDT- 2019/01/10 06:00 PHST- 2019/01/10 06:00 [pubmed] PHST- 2019/03/07 06:00 [medline] PHST- 2019/01/10 06:00 [entrez] AID - 10.1111/jocs.13976 [doi] PST - ppublish SO - J Card Surg. 2019 Jan;34(1):7-13. doi: 10.1111/jocs.13976. Epub 2019 Jan 9.